Clinical Trials
49 trialsTesting the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
SWOG Cancer Research Network
SHARON
General Oncology, Inc.
The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.
Lo.Li.Pharma s.r.l
Intrathecal Pemetrexed for Leptomeningeal Metastasis
The First Hospital of Jilin University
CONTERNO
Checkpoint Therapeutics, Inc.
The Effect of Natural Molecules on HPV Infection
AGUNCO Obstetrics and Gynecology Centre
MK-3475-189
Merck Sharp & Dohme LLC
Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast Cancer
Case Comprehensive Cancer Center
MK-3475-189
Merck Sharp & Dohme LLC
Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions
Lo.Li.Pharma s.r.l
KEAPSAKE
Calithera Biosciences, Inc
Management of Preoperative Anaemia in Surgical Oncology
Azienda Ospedaliera Universitaria Integrata Verona
Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients
NSABP Foundation Inc
Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
SCRI Development Innovations, LLC
Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Spectrum Pharmaceuticals, Inc
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
Spectrum Pharmaceuticals, Inc
Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia Patients
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies
Acrotech Biopharma Inc.
Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer
Acrotech Biopharma Inc.
Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Acrotech Biopharma Inc.
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Acrotech Biopharma Inc.
Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
Acrotech Biopharma Inc.
Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies
Acrotech Biopharma Inc.
A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL
Mundipharma (China) Pharmaceutical Co. Ltd
A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer
Eli Lilly and Company
CIPN
AHS Cancer Control Alberta
Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme
Case Comprehensive Cancer Center
Can B12 and Folate Levels Predict HPV Penetration in Patients With ASCUS?
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer
The First Hospital of Jilin University
Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis
Second Affiliated Hospital of Nanchang University
Vitamin B12 for Aromatase Inhibitors Musculoskeletal Symptoms
Texas Tech University Health Sciences Center, El Paso
Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer
Massachusetts General Hospital
Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
Mundipharma K.K.
PREMIER
Asan Medical Center
PEMVITASTART
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 2 Trial of Bevacizumab in Combination With Pemetrexed
Stanford University
Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
Boehringer Ingelheim
Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer
Hoosier Cancer Research Network
AP/GP
Sun Yat-sen University
Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT
Sun Yat-sen University
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients
New Mexico Cancer Research Alliance
Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
Memorial Sloan Kettering Cancer Center
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Eli Lilly and Company
SKOPOS
Wales Cancer Trials Unit
Oral Vitamin B12 Administration for Vitamin B12 Deficiency After Total Gastrectomy
Yonsei University
Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer
Eli Lilly and Company
HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)
McMaster University